The Cancer Researcher
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
The Cancer Researcher
No Result
View All Result

Highlights in Cancer Research: August 2023

October 17, 2025
Highlights in Cancer Research: November 2022

The EACR’s ‘Highlights in Cancer Research’ is a regular summary of the most interesting and impactful recent papers in cancer research, curated by the Board of the European Association for Cancer Research (EACR).

The list below appears in no particular order, and the summary information has been provided by the authors unless otherwise indicated.

Use the dropdown menu or ‘Previous’ and ‘Next’ buttons to navigate the list.

1. Epigenetic plasticity cooperates with cell-cell interactions to direct pancreatic tumorigenesis

  • 1. Epigenetic plasticity cooperates with cell-cell interactions to direct pancreatic tumorigenesis
  • 2. Dysregulated Lipid Synthesis by Oncogenic IDH1 Mutation Is a Targetable Synthetic Lethal Vulnerability
  • 3. Single-cell spatial immune landscapes of primary and metastatic brain tumours
  • 4. Multiplexed 3D atlas of state transitions and immune interaction in colorectal cancer
  • 5. A microbiota-modulated checkpoint directs immunosuppressive intestinal T cells into cancers
  • 6. Tissue memory relies on stem cell priming in distal undamaged areas
  • 7. Stepwise activities of mSWI/SNF family chromatin remodeling complexes direct T cell activation and exhaustion
  • 8. Distant antimetastatic effect of enterotropic colon cancer-derived α4β7+CD8+ T cells
  • 9. Tumour extracellular vesicles and particles induce liver metabolic dysfunction
  • 10. A neutrophil response linked to tumor control in immunotherapy
  • 11.
Previous
Next

Burdziak, C., Alonso-Curbelo, D. et al. Science. 380 (6645): eadd5327 (2023).
doi: 10.1126/science.add5327.

Summary of the findings

Pancreatic cancer is typically diagnosed late, with few treatment options, motivating a search for early intervention strategies to improve outcomes. In this paper, the authors leveraged genetically engineered mouse models to obtain a high-resolution view of pancreatic tissue during the earliest stages of cancer progression. Single-cell transcriptomic sequencing identified cellular phenotypes that are absent from normal pancreatic epithelia, but emerge following oncogenic Kras mutation. Exposure of these cells to inflammation—a condition known to provoke the onset of rapid tumorigenesis—triggers a transition toward neoplastic states from several distinct cellular origins. Among these, a highly plastic, Nestin-expressing progenitor-like population serves as the precursor for neoplastic states that predominate in the pancreas weeks or months later. By integrating epigenetic data, the authors revealed that highly plastic populations undergo global chromatin reprogramming, heightened in the vicinity of cell-cell communication genes, which alter the way these cells send and receive signals from their environment. They developed a computational approach to catalogue the set of receptors and ligands that define the communication capabilities of each plastic epithelial state and linked these ‘communication modules’ with relevant modules in tissue immune cells to define a pre-malignant cell-cell interaction network. This analysis identified a feedback loop between epithelial cells and regulatory T cells in the microenvironment, which drives the exit from plastic states toward neoplastic endpoints.
A genetically engineered mouse model harboring mutant Kras in the pancreatic epithelium is subject to inflammation, inducing pancreatitis-driven tumorigenesis. Within 48 hours, chromatin opening near cell-cell communication genes opens channels of communication in plastic cells. Emergent signaling from gastric-like populations to progenitor-like cells involves multiple receptor-ligand pairs. Mouse illustration was created with BioRender (https://biorender.com/).

Future impact

This work sheds light on the earliest events driving cancer progression, focusing on how genetic mutation cooperates with environmental factors such as inflammation to initiate disease. The cellular plasticity and cell-cell communication mechanisms that are shown to underly disease onset and early progression provide several potential targets for cancer therapeutics.

Read more in Science

1. Epigenetic plasticity cooperates with cell-cell interactions to direct pancreatic tumorigenesis

  • 1. Epigenetic plasticity cooperates with cell-cell interactions to direct pancreatic tumorigenesis
  • 2. Dysregulated Lipid Synthesis by Oncogenic IDH1 Mutation Is a Targetable Synthetic Lethal Vulnerability
  • 3. Single-cell spatial immune landscapes of primary and metastatic brain tumours
  • 4. Multiplexed 3D atlas of state transitions and immune interaction in colorectal cancer
  • 5. A microbiota-modulated checkpoint directs immunosuppressive intestinal T cells into cancers
  • 6. Tissue memory relies on stem cell priming in distal undamaged areas
  • 7. Stepwise activities of mSWI/SNF family chromatin remodeling complexes direct T cell activation and exhaustion
  • 8. Distant antimetastatic effect of enterotropic colon cancer-derived α4β7+CD8+ T cells
  • 9. Tumour extracellular vesicles and particles induce liver metabolic dysfunction
  • 10. A neutrophil response linked to tumor control in immunotherapy
  • 11.
Previous
Next
Tags: EACR Top Ten Cancer Research PublicationsHighlights in Cancer Research

Related Posts

“The best scientific event I have ever participated in”: Rafaela’s EACR Travel Grant leads to new opportunities

“The best scientific event I have ever participated in”: Rafaela’s EACR Travel Grant leads to new opportunities

April 20, 2026

The EACR, AACR, and The Mark Foundation for Cancer Research recently teamed up to offer a number of travel grants to help EACR or AACR members...

VIDEO | Streamlining Tumour Interpretation with the Cancer Genome Interpreter

VIDEO | Streamlining Tumour Interpretation with the Cancer Genome Interpreter

April 22, 2026

https://www.youtube.com/watch?v=KdMqmIIgNYo Click above to watch On 9 April 2026, the EACR hosted a free webinar bringing together leading experts to explore the Cancer Genome Interpreter (CGI)...

Patients Shaping Cancer Research – Episode 31 of The Cancer Researcher Podcast

Patients Shaping Cancer Research – Episode 31 of The Cancer Researcher Podcast

April 13, 2026

What does it take to bridge the gap between researchers and patients? In this episode, scientists, oncologists, and patient advocates from Canada, the United States, and...

The Cancer Researcher EACR logo

About Us

The Cancer Researcher is an online magazine for the cancer research community from the European Association for Cancer Research.

The EACR, a registered charity, is a global community for those working and studying in cancer research. Our mission is “The advancement of cancer research for the public benefit: from basic research to prevention, treatment and care.”

RECENT POSTS

“The best scientific event I have ever participated in”: Rafaela’s EACR Travel Grant leads to new opportunities
Community

“The best scientific event I have ever participated in”: Rafaela’s EACR Travel Grant leads to new opportunities

April 20, 2026
VIDEO | Streamlining Tumour Interpretation with the Cancer Genome Interpreter
Features

VIDEO | Streamlining Tumour Interpretation with the Cancer Genome Interpreter

April 22, 2026
The Cancer Researcher

© 2025 EACR

Navigate site

  • About
  • Privacy
  • Main EACR website

Follow us

No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious

© 2025 EACR